PUBLICATION

Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.


PUBLICATION ARCHIVES

SEARCH THE ARCHIVES

Issue #2, February 2002

Journal Top Ten


Study of Cardiovascular Patients Reveals Majority Use Alternative Medicine


DEA to House: Oxycontin Maker Partially Responsible for Drug Abuse and Deaths


FDA to Consider Reintroduction of GlaxoSmithKline Drug Lotronex


The FDA Drug Approval Process: Risks v. Benefits


The Warnings Page: Ephedra Recall in Canada; FDA Investigates Kava; Bristol-Myers, Novartis Issue Warnings


Bayer Lists Stock on New York Exchange Amid Marked Increase in Reported Baycol Deaths, Management Shake-Up


Plaintiffs Seek to Delete Class Action Allegations and Pursue Individual Claims

In a Jan. 17 motion for leave to amend their complaint, the plaintiffs in an OxyContin class action in Virginia have requested that the class action allegations be deleted without prejudice in the interest of pursuing individual claims.


Plaintiffs Argue That Injunctive Relief in Vioxx/Celebrex Suit Not Preempted by FDA Regulation

Plaintiffs seeking injunctive relief under New York law in a Vioxx/Celebrex class action lawsuit have urged a New York federal court to deny defendants' motion to dismiss


Plaintiffs File Suit Against Bayer Seeking Class Certification and Medical Monitoring Fund

Alleging numerous Baycol-related injuries, three plaintiffs have filed a class action lawsuit in federal court in Arkansas seeking, among other things, to establish


Past Issues:


VERDICTRACK

The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.

  • DEFENDANT
  • DISEASE / INJURY
  • PRODUCT
  • PUBLICATION
  • STATE
  • SEARCH BY EXPERT
True